Ropes & Gray represented HUTCHMED on the deal. HUTCHMED (China) Limited and its subsidiary, HUTCHMED Limited announced an exclusive worldwide license agreement with Japan’s largest drugmaker Takeda...
HUTCHMED’s License Agreement with Takeda Pharmaceutical
HUTCHMED’s HK$ 4.17 Billion Initial Public Offering
DLA Piper advised HUTCHMED, while Linklaters and Davis Polk advised the joint sponsors and underwriters on the global offering and listing of HUTCHMED (China) Limited on...